BMEA
Biomea Fusion, Inc.Company Information
- Company Name
- Biomea Fusion, Inc.
- CIK
- CIK0001840439
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- BMEA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BMEA
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-12-11
- Last sale
- 2023-06-01
- Shares purchased (TTM)
- 140,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 24,922,958
- Shares outstanding
- 72,360,235
- Ownership
- 34.44%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 37.30%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 35 | 45 | 56 | 47 | 56 | 36 | 58 | 88 | 113 | 145 | 177 | 199 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 2 | 3 | 8 | 9 | 10 | 6 | 3 | 3 | 2 | 3 | ||||||
| Restricted Cash Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 36 | 46 | 58 | 49 | 65 | 45 | 68 | 94 | 116 | 148 | 179 | 203 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 6 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Restricted Cash | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | - | 0 | 0 | 0 | 1 | 1 | 5 | 7 | 7 | 6 | 5 | ||||||
| Operating Lease Right Of Use Asset | - | - | 0 | 5 | 5 | 6 | 7 | 8 | 8 | 9 | 10 | 12 | ||||||
| Assets | 37 | 46 | 59 | 55 | 73 | 55 | 80 | 110 | 136 | 168 | 200 | 225 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 5 | 3 | 6 | 8 | 8 | 13 | 9 | 6 | 5 | 7 | 3 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 2 | 3 | ||||||
| Liabilities Current | 10 | 9 | 11 | 16 | 18 | 20 | 22 | 28 | 25 | 25 | 23 | 16 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 9 | ||||||
| Liabilities | 25 | 28 | 29 | 40 | 46 | 26 | 28 | 34 | 32 | 33 | 31 | 25 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 482 | 480 | 479 | 469 | 465 | 445 | 439 | 434 | 429 | 423 | 418 | 414 | ||||||
| Retained Earnings Accumulated Deficit | -470 | -461 | -449 | -454 | -437 | -417 | -387 | -358 | -325 | -288 | -249 | -214 | ||||||
| Stockholders Equity | 12 | 19 | 30 | 16 | 28 | 29 | 52 | 76 | 104 | 135 | 169 | 200 | ||||||
| Liabilities And Stockholders Equity | 37 | 46 | 59 | 55 | 73 | 55 | 80 | 110 | 136 | 168 | 200 | 225 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 72 | 72 | 72 | 60 | 58 | 38 | 36 | 36 | 36 | 36 | 36 | 36 | ||||||
| Shares Outstanding | 72 | 72 | 72 | 60 | 58 | 38 | 36 | 36 | 36 | 36 | 36 | 36 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBiomea Fusion, Inc. (BMEA) — SEC Financial Statements & Analysis
Biomea Fusion, Inc. (BMEA) is a pharmaceutical preparations company, incorporated in DE. Biomea Fusion, Inc. trades on Nasdaq as: BMEA. Biomea Fusion, Inc. (BMEA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Biomea Fusion, Inc. carries a market cap of $106.37M, a P/E ratio of -3.27x, a P/B ratio of 8.76x, an enterprise value of $71.18M, and an EV/EBITDA multiple of -1.24x. On profitability, it posts a Return on Equity (ROE) of -164.14% and a Return on Assets (ROA) of -59.14%. Per share, it reports EPS of $-0.45, diluted EPS of $-0.45, free cash flow per share of $-0.65, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -70.97% year-over-year and EPS growth of -83.70% year-over-year. On the balance sheet, it maintains a current ratio of 3.47x, a quick ratio of 3.36x, working capital of $25.95M, a debt-to-equity ratio of 2.04x, a debt ratio of 0.67, free cash flow of $-47.19M (TTM), and net debt of $-35.19M. Figures sourced from SEC EDGAR.
- Market Cap
- $106.37M
- P/E TTM
- -3.27x
- EPS TTM
- $-0.45
- P/B TTM
- 8.76x
- ROE TTM
- -164.14%
- ROA TTM
- -59.14%
- Debt To Equity
- 2.04x
- Free Cash Flow TTM
- $-47.19M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Biomea Fusion, Inc. in?
Biomea Fusion, Inc. (BMEA) operates in the Pharmaceutical Preparations industry.
What exchange does BMEA trade on?
Biomea Fusion, Inc. (BMEA) trades on the Nasdaq.
Where is Biomea Fusion, Inc. incorporated?
Biomea Fusion, Inc. is incorporated in DE.
When was Biomea Fusion, Inc. (BMEA)'s most recent SEC filing?
Biomea Fusion, Inc. (BMEA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is BMEA's market cap?
Biomea Fusion, Inc. (BMEA) has a market capitalization of $106.37M as of 2026-06-30.
What is BMEA's EPS (earnings per share)?
Biomea Fusion, Inc. (BMEA)'s trailing twelve month EPS is $-0.45 as of 2026-06-30.
What is BMEA's ROE (return on equity)?
Biomea Fusion, Inc. (BMEA)'s trailing twelve month Return on Equity (ROE) is -164.14% as of 2026-06-30.
What is BMEA's ROA (return on assets)?
Biomea Fusion, Inc. (BMEA)'s trailing twelve month Return on Assets (ROA) is -59.14% as of 2026-06-30.
What is BMEA's EV/EBITDA?
Biomea Fusion, Inc. (BMEA)'s trailing twelve month EV/EBITDA is -1.24x as of 2026-06-30.